The global Antipsychotic Drug market was valued at million in 2024 and is projected to reach US$ million by 2032, at a CAGR of %during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
We have surveyed the Antipsychotic Drug companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks
This report aims to provide a comprehensive presentation of the global market for Antipsychotic Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antipsychotic Drug. This report contains market size and forecasts of Antipsychotic Drug in global, including the following market information:
Global Antipsychotic Drug market revenue, 2020-2025, 2026-2032, ($ millions)
Global top five Antipsychotic Drug companies in 2024 (%)
Total Market by Segment:
Global Antipsychotic Drug market, by Type, 2020-2025, 2026-2032 ($ millions)
Global Antipsychotic Drug market segment percentages, by Type, 2024 (%)
First Generation Antipsychotics Drug
Second Generation Antipsychotics Drug
Third generation Antipsychotics Drug
Global Antipsychotic Drug market, by Application, 2020-2025, 2026-2032 ($ millions)
Global Antipsychotic Drug market segment percentages, by Application, 2024 (%)
Bipolar I Disorder
Schizophrenia
Schizoaffective Disorder
Others
Global Antipsychotic Drug market, by region and country, 2020-2025, 2026-2032 ($ millions)
Global Antipsychotic Drug market segment percentages, by region and country, 2024 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Antipsychotic Drug revenues in global market, 2020-2025 (estimated), ($ millions)
Key companies Antipsychotic Drug revenues share in global market, 2024 (%)
Further, the report presents profiles of competitors in the market, key players include:
Johnson & Johnson
Pfizer
Eli Lilly
Bristol Myers Squibb
AstraZeneca
Sumitomo Dainippon Pharma
Allergan
Novartis
Cardinal Health
Sun Pharmaceutical Industries
GlaxoSmithKline
Sanis Health
Qilu Pharmaceutical
Otsuka Pharmaceutical
Vanda Pharmaceuticals
H.Lundbeck
Organon
Hansoh
Hengrui
Nhwa Group
Yangtze River Pharmaceutical Group
Outline of Major Chapters:
Chapter 1: Introduces the definition of Antipsychotic Drug, market overview.
Chapter 2: Global Antipsychotic Drug market size in revenue.
Chapter 3: Detailed analysis of Antipsychotic Drug company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Antipsychotic Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Antipsychotic Drug Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 Global Antipsychotic Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Antipsychotic Drug Overall Market Size
2.1 Global Antipsychotic Drug Market Size: 2024 VS 2032
2.2 Global Antipsychotic Drug Market Size, Prospects & Forecasts: 2020-2032
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Antipsychotic Drug Players in Global Market
3.2 Top Global Antipsychotic Drug Companies Ranked by Revenue
3.3 Global Antipsychotic Drug Revenue by Companies
3.4 Top 3 and Top 5 Antipsychotic Drug Companies in Global Market, by Revenue in 2024
3.5 Global Companies Antipsychotic Drug Product Type
3.6 Tier 1, Tier 2, and Tier 3 Antipsychotic Drug Players in Global Market
3.6.1 List of Global Tier 1 Antipsychotic Drug Companies
3.6.2 List of Global Tier 2 and Tier 3 Antipsychotic Drug Companies
4 Sights by Product
4.1 Overview
4.1.1 Segmentation by Type - Global Antipsychotic Drug Market Size Markets, 2024 & 2032
4.1.2 First Generation Antipsychotics Drug
4.1.3 Second Generation Antipsychotics Drug
4.1.4 Third generation Antipsychotics Drug
4.2 Segmentation by Type - Global Antipsychotic Drug Revenue & Forecasts
4.2.1 Segmentation by Type - Global Antipsychotic Drug Revenue, 2020-2025
4.2.2 Segmentation by Type - Global Antipsychotic Drug Revenue, 2026-2032
4.2.3 Segmentation by Type - Global Antipsychotic Drug Revenue Market Share, 2020-2032
5 Sights by Application
5.1 Overview
5.1.1 Segmentation by Application - Global Antipsychotic Drug Market Size, 2024 & 2032
5.1.2 Bipolar I Disorder
5.1.3 Schizophrenia
5.1.4 Schizoaffective Disorder
5.1.5 Others
5.2 Segmentation by Application - Global Antipsychotic Drug Revenue & Forecasts
5.2.1 Segmentation by Application - Global Antipsychotic Drug Revenue, 2020-2025
5.2.2 Segmentation by Application - Global Antipsychotic Drug Revenue, 2026-2032
5.2.3 Segmentation by Application - Global Antipsychotic Drug Revenue Market Share, 2020-2032
6 Sights by Region
6.1 By Region - Global Antipsychotic Drug Market Size, 2024 & 2032
6.2 By Region - Global Antipsychotic Drug Revenue & Forecasts
6.2.1 By Region - Global Antipsychotic Drug Revenue, 2020-2025
6.2.2 By Region - Global Antipsychotic Drug Revenue, 2026-2032
6.2.3 By Region - Global Antipsychotic Drug Revenue Market Share, 2020-2032
6.3 North America
6.3.1 By Country - North America Antipsychotic Drug Revenue, 2020-2032
6.3.2 United States Antipsychotic Drug Market Size, 2020-2032
6.3.3 Canada Antipsychotic Drug Market Size, 2020-2032
6.3.4 Mexico Antipsychotic Drug Market Size, 2020-2032
6.4 Europe
6.4.1 By Country - Europe Antipsychotic Drug Revenue, 2020-2032
6.4.2 Germany Antipsychotic Drug Market Size, 2020-2032
6.4.3 France Antipsychotic Drug Market Size, 2020-2032
6.4.4 U.K. Antipsychotic Drug Market Size, 2020-2032
6.4.5 Italy Antipsychotic Drug Market Size, 2020-2032
6.4.6 Russia Antipsychotic Drug Market Size, 2020-2032
6.4.7 Nordic Countries Antipsychotic Drug Market Size, 2020-2032
6.4.8 Benelux Antipsychotic Drug Market Size, 2020-2032
6.5 Asia
6.5.1 By Region - Asia Antipsychotic Drug Revenue, 2020-2032
6.5.2 China Antipsychotic Drug Market Size, 2020-2032
6.5.3 Japan Antipsychotic Drug Market Size, 2020-2032
6.5.4 South Korea Antipsychotic Drug Market Size, 2020-2032
6.5.5 Southeast Asia Antipsychotic Drug Market Size, 2020-2032
6.5.6 India Antipsychotic Drug Market Size, 2020-2032
6.6 South America
6.6.1 By Country - South America Antipsychotic Drug Revenue, 2020-2032
6.6.2 Brazil Antipsychotic Drug Market Size, 2020-2032
6.6.3 Argentina Antipsychotic Drug Market Size, 2020-2032
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Antipsychotic Drug Revenue, 2020-2032
6.7.2 Turkey Antipsychotic Drug Market Size, 2020-2032
6.7.3 Israel Antipsychotic Drug Market Size, 2020-2032
6.7.4 Saudi Arabia Antipsychotic Drug Market Size, 2020-2032
6.7.5 UAE Antipsychotic Drug Market Size, 2020-2032
7 Companies Profiles
7.1 Johnson & Johnson
7.1.1 Johnson & Johnson Corporate Summary
7.1.2 Johnson & Johnson Business Overview
7.1.3 Johnson & Johnson Antipsychotic Drug Major Product Offerings
7.1.4 Johnson & Johnson Antipsychotic Drug Revenue in Global Market (2020-2025)
7.1.5 Johnson & Johnson Key News & Latest Developments
7.2 Pfizer
7.2.1 Pfizer Corporate Summary
7.2.2 Pfizer Business Overview
7.2.3 Pfizer Antipsychotic Drug Major Product Offerings
7.2.4 Pfizer Antipsychotic Drug Revenue in Global Market (2020-2025)
7.2.5 Pfizer Key News & Latest Developments
7.3 Eli Lilly
7.3.1 Eli Lilly Corporate Summary
7.3.2 Eli Lilly Business Overview
7.3.3 Eli Lilly Antipsychotic Drug Major Product Offerings
7.3.4 Eli Lilly Antipsychotic Drug Revenue in Global Market (2020-2025)
7.3.5 Eli Lilly Key News & Latest Developments
7.4 Bristol Myers Squibb
7.4.1 Bristol Myers Squibb Corporate Summary
7.4.2 Bristol Myers Squibb Business Overview
7.4.3 Bristol Myers Squibb Antipsychotic Drug Major Product Offerings
7.4.4 Bristol Myers Squibb Antipsychotic Drug Revenue in Global Market (2020-2025)
7.4.5 Bristol Myers Squibb Key News & Latest Developments
7.5 AstraZeneca
7.5.1 AstraZeneca Corporate Summary
7.5.2 AstraZeneca Business Overview
7.5.3 AstraZeneca Antipsychotic Drug Major Product Offerings
7.5.4 AstraZeneca Antipsychotic Drug Revenue in Global Market (2020-2025)
7.5.5 AstraZeneca Key News & Latest Developments
7.6 Sumitomo Dainippon Pharma
7.6.1 Sumitomo Dainippon Pharma Corporate Summary
7.6.2 Sumitomo Dainippon Pharma Business Overview
7.6.3 Sumitomo Dainippon Pharma Antipsychotic Drug Major Product Offerings
7.6.4 Sumitomo Dainippon Pharma Antipsychotic Drug Revenue in Global Market (2020-2025)
7.6.5 Sumitomo Dainippon Pharma Key News & Latest Developments
7.7 Allergan
7.7.1 Allergan Corporate Summary
7.7.2 Allergan Business Overview
7.7.3 Allergan Antipsychotic Drug Major Product Offerings
7.7.4 Allergan Antipsychotic Drug Revenue in Global Market (2020-2025)
7.7.5 Allergan Key News & Latest Developments
7.8 Novartis
7.8.1 Novartis Corporate Summary
7.8.2 Novartis Business Overview
7.8.3 Novartis Antipsychotic Drug Major Product Offerings
7.8.4 Novartis Antipsychotic Drug Revenue in Global Market (2020-2025)
7.8.5 Novartis Key News & Latest Developments
7.9 Cardinal Health
7.9.1 Cardinal Health Corporate Summary
7.9.2 Cardinal Health Business Overview
7.9.3 Cardinal Health Antipsychotic Drug Major Product Offerings
7.9.4 Cardinal Health Antipsychotic Drug Revenue in Global Market (2020-2025)
7.9.5 Cardinal Health Key News & Latest Developments
7.10 Sun Pharmaceutical Industries
7.10.1 Sun Pharmaceutical Industries Corporate Summary
7.10.2 Sun Pharmaceutical Industries Business Overview
7.10.3 Sun Pharmaceutical Industries Antipsychotic Drug Major Product Offerings
7.10.4 Sun Pharmaceutical Industries Antipsychotic Drug Revenue in Global Market (2020-2025)
7.10.5 Sun Pharmaceutical Industries Key News & Latest Developments
7.11 GlaxoSmithKline
7.11.1 GlaxoSmithKline Corporate Summary
7.11.2 GlaxoSmithKline Business Overview
7.11.3 GlaxoSmithKline Antipsychotic Drug Major Product Offerings
7.11.4 GlaxoSmithKline Antipsychotic Drug Revenue in Global Market (2020-2025)
7.11.5 GlaxoSmithKline Key News & Latest Developments
7.12 Sanis Health
7.12.1 Sanis Health Corporate Summary
7.12.2 Sanis Health Business Overview
7.12.3 Sanis Health Antipsychotic Drug Major Product Offerings
7.12.4 Sanis Health Antipsychotic Drug Revenue in Global Market (2020-2025)
7.12.5 Sanis Health Key News & Latest Developments
7.13 Qilu Pharmaceutical
7.13.1 Qilu Pharmaceutical Corporate Summary
7.13.2 Qilu Pharmaceutical Business Overview
7.13.3 Qilu Pharmaceutical Antipsychotic Drug Major Product Offerings
7.13.4 Qilu Pharmaceutical Antipsychotic Drug Revenue in Global Market (2020-2025)
7.13.5 Qilu Pharmaceutical Key News & Latest Developments
7.14 Otsuka Pharmaceutical
7.14.1 Otsuka Pharmaceutical Corporate Summary
7.14.2 Otsuka Pharmaceutical Business Overview
7.14.3 Otsuka Pharmaceutical Antipsychotic Drug Major Product Offerings
7.14.4 Otsuka Pharmaceutical Antipsychotic Drug Revenue in Global Market (2020-2025)
7.14.5 Otsuka Pharmaceutical Key News & Latest Developments
7.15 Vanda Pharmaceuticals
7.15.1 Vanda Pharmaceuticals Corporate Summary
7.15.2 Vanda Pharmaceuticals Business Overview
7.15.3 Vanda Pharmaceuticals Antipsychotic Drug Major Product Offerings
7.15.4 Vanda Pharmaceuticals Antipsychotic Drug Revenue in Global Market (2020-2025)
7.15.5 Vanda Pharmaceuticals Key News & Latest Developments
7.16 H.Lundbeck
7.16.1 H.Lundbeck Corporate Summary
7.16.2 H.Lundbeck Business Overview
7.16.3 H.Lundbeck Antipsychotic Drug Major Product Offerings
7.16.4 H.Lundbeck Antipsychotic Drug Revenue in Global Market (2020-2025)
7.16.5 H.Lundbeck Key News & Latest Developments
7.17 Organon
7.17.1 Organon Corporate Summary
7.17.2 Organon Business Overview
7.17.3 Organon Antipsychotic Drug Major Product Offerings
7.17.4 Organon Antipsychotic Drug Revenue in Global Market (2020-2025)
7.17.5 Organon Key News & Latest Developments
7.18 Hansoh
7.18.1 Hansoh Corporate Summary
7.18.2 Hansoh Business Overview
7.18.3 Hansoh Antipsychotic Drug Major Product Offerings
7.18.4 Hansoh Antipsychotic Drug Revenue in Global Market (2020-2025)
7.18.5 Hansoh Key News & Latest Developments
7.19 Hengrui
7.19.1 Hengrui Corporate Summary
7.19.2 Hengrui Business Overview
7.19.3 Hengrui Antipsychotic Drug Major Product Offerings
7.19.4 Hengrui Antipsychotic Drug Revenue in Global Market (2020-2025)
7.19.5 Hengrui Key News & Latest Developments
7.20 Nhwa Group
7.20.1 Nhwa Group Corporate Summary
7.20.2 Nhwa Group Business Overview
7.20.3 Nhwa Group Antipsychotic Drug Major Product Offerings
7.20.4 Nhwa Group Antipsychotic Drug Revenue in Global Market (2020-2025)
7.20.5 Nhwa Group Key News & Latest Developments
7.21 Yangtze River Pharmaceutical Group
7.21.1 Yangtze River Pharmaceutical Group Corporate Summary
7.21.2 Yangtze River Pharmaceutical Group Business Overview
7.21.3 Yangtze River Pharmaceutical Group Antipsychotic Drug Major Product Offerings
7.21.4 Yangtze River Pharmaceutical Group Antipsychotic Drug Revenue in Global Market (2020-2025)
7.21.5 Yangtze River Pharmaceutical Group Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Antipsychotic Drug Market Opportunities & Trends in Global Market
Table 2. Antipsychotic Drug Market Drivers in Global Market
Table 3. Antipsychotic Drug Market Restraints in Global Market
Table 4. Key Players of Antipsychotic Drug in Global Market
Table 5. Top Antipsychotic Drug Players in Global Market, Ranking by Revenue (2024)
Table 6. Global Antipsychotic Drug Revenue by Companies, (US$, Mn), 2020-2025
Table 7. Global Antipsychotic Drug Revenue Share by Companies, 2020-2025
Table 8. Global Companies Antipsychotic Drug Product Type
Table 9. List of Global Tier 1 Antipsychotic Drug Companies, Revenue (US$, Mn) in 2024 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Antipsychotic Drug Companies, Revenue (US$, Mn) in 2024 and Market Share
Table 11. Segmentation by Type � Global Antipsychotic Drug Revenue, (US$, Mn), 2024 & 2032
Table 12. Segmentation by Type - Global Antipsychotic Drug Revenue (US$, Mn), 2020-2025
Table 13. Segmentation by Type - Global Antipsychotic Drug Revenue (US$, Mn), 2026-2032
Table 14. Segmentation by Application� Global Antipsychotic Drug Revenue, (US$, Mn), 2024 & 2032
Table 15. Segmentation by Application - Global Antipsychotic Drug Revenue, (US$, Mn), 2020-2025
Table 16. Segmentation by Application - Global Antipsychotic Drug Revenue, (US$, Mn), 2026-2032
Table 17. By Region� Global Antipsychotic Drug Revenue, (US$, Mn), 2024 & 2032
Table 18. By Region - Global Antipsychotic Drug Revenue, (US$, Mn), 2020-2025
Table 19. By Region - Global Antipsychotic Drug Revenue, (US$, Mn), 2026-2032
Table 20. By Country - North America Antipsychotic Drug Revenue, (US$, Mn), 2020-2025
Table 21. By Country - North America Antipsychotic Drug Revenue, (US$, Mn), 2026-2032
Table 22. By Country - Europe Antipsychotic Drug Revenue, (US$, Mn), 2020-2025
Table 23. By Country - Europe Antipsychotic Drug Revenue, (US$, Mn), 2026-2032
Table 24. By Region - Asia Antipsychotic Drug Revenue, (US$, Mn), 2020-2025
Table 25. By Region - Asia Antipsychotic Drug Revenue, (US$, Mn), 2026-2032
Table 26. By Country - South America Antipsychotic Drug Revenue, (US$, Mn), 2020-2025
Table 27. By Country - South America Antipsychotic Drug Revenue, (US$, Mn), 2026-2032
Table 28. By Country - Middle East & Africa Antipsychotic Drug Revenue, (US$, Mn), 2020-2025
Table 29. By Country - Middle East & Africa Antipsychotic Drug Revenue, (US$, Mn), 2026-2032
Table 30. Johnson & Johnson Corporate Summary
Table 31. Johnson & Johnson Antipsychotic Drug Product Offerings
Table 32. Johnson & Johnson Antipsychotic Drug Revenue (US$, Mn) & (2020-2025)
Table 33. Johnson & Johnson Key News & Latest Developments
Table 34. Pfizer Corporate Summary
Table 35. Pfizer Antipsychotic Drug Product Offerings
Table 36. Pfizer Antipsychotic Drug Revenue (US$, Mn) & (2020-2025)
Table 37. Pfizer Key News & Latest Developments
Table 38. Eli Lilly Corporate Summary
Table 39. Eli Lilly Antipsychotic Drug Product Offerings
Table 40. Eli Lilly Antipsychotic Drug Revenue (US$, Mn) & (2020-2025)
Table 41. Eli Lilly Key News & Latest Developments
Table 42. Bristol Myers Squibb Corporate Summary
Table 43. Bristol Myers Squibb Antipsychotic Drug Product Offerings
Table 44. Bristol Myers Squibb Antipsychotic Drug Revenue (US$, Mn) & (2020-2025)
Table 45. Bristol Myers Squibb Key News & Latest Developments
Table 46. AstraZeneca Corporate Summary
Table 47. AstraZeneca Antipsychotic Drug Product Offerings
Table 48. AstraZeneca Antipsychotic Drug Revenue (US$, Mn) & (2020-2025)
Table 49. AstraZeneca Key News & Latest Developments
Table 50. Sumitomo Dainippon Pharma Corporate Summary
Table 51. Sumitomo Dainippon Pharma Antipsychotic Drug Product Offerings
Table 52. Sumitomo Dainippon Pharma Antipsychotic Drug Revenue (US$, Mn) & (2020-2025)
Table 53. Sumitomo Dainippon Pharma Key News & Latest Developments
Table 54. Allergan Corporate Summary
Table 55. Allergan Antipsychotic Drug Product Offerings
Table 56. Allergan Antipsychotic Drug Revenue (US$, Mn) & (2020-2025)
Table 57. Allergan Key News & Latest Developments
Table 58. Novartis Corporate Summary
Table 59. Novartis Antipsychotic Drug Product Offerings
Table 60. Novartis Antipsychotic Drug Revenue (US$, Mn) & (2020-2025)
Table 61. Novartis Key News & Latest Developments
Table 62. Cardinal Health Corporate Summary
Table 63. Cardinal Health Antipsychotic Drug Product Offerings
Table 64. Cardinal Health Antipsychotic Drug Revenue (US$, Mn) & (2020-2025)
Table 65. Cardinal Health Key News & Latest Developments
Table 66. Sun Pharmaceutical Industries Corporate Summary
Table 67. Sun Pharmaceutical Industries Antipsychotic Drug Product Offerings
Table 68. Sun Pharmaceutical Industries Antipsychotic Drug Revenue (US$, Mn) & (2020-2025)
Table 69. Sun Pharmaceutical Industries Key News & Latest Developments
Table 70. GlaxoSmithKline Corporate Summary
Table 71. GlaxoSmithKline Antipsychotic Drug Product Offerings
Table 72. GlaxoSmithKline Antipsychotic Drug Revenue (US$, Mn) & (2020-2025)
Table 73. GlaxoSmithKline Key News & Latest Developments
Table 74. Sanis Health Corporate Summary
Table 75. Sanis Health Antipsychotic Drug Product Offerings
Table 76. Sanis Health Antipsychotic Drug Revenue (US$, Mn) & (2020-2025)
Table 77. Sanis Health Key News & Latest Developments
Table 78. Qilu Pharmaceutical Corporate Summary
Table 79. Qilu Pharmaceutical Antipsychotic Drug Product Offerings
Table 80. Qilu Pharmaceutical Antipsychotic Drug Revenue (US$, Mn) & (2020-2025)
Table 81. Qilu Pharmaceutical Key News & Latest Developments
Table 82. Otsuka Pharmaceutical Corporate Summary
Table 83. Otsuka Pharmaceutical Antipsychotic Drug Product Offerings
Table 84. Otsuka Pharmaceutical Antipsychotic Drug Revenue (US$, Mn) & (2020-2025)
Table 85. Otsuka Pharmaceutical Key News & Latest Developments
Table 86. Vanda Pharmaceuticals Corporate Summary
Table 87. Vanda Pharmaceuticals Antipsychotic Drug Product Offerings
Table 88. Vanda Pharmaceuticals Antipsychotic Drug Revenue (US$, Mn) & (2020-2025)
Table 89. Vanda Pharmaceuticals Key News & Latest Developments
Table 90. H.Lundbeck Corporate Summary
Table 91. H.Lundbeck Antipsychotic Drug Product Offerings
Table 92. H.Lundbeck Antipsychotic Drug Revenue (US$, Mn) & (2020-2025)
Table 93. H.Lundbeck Key News & Latest Developments
Table 94. Organon Corporate Summary
Table 95. Organon Antipsychotic Drug Product Offerings
Table 96. Organon Antipsychotic Drug Revenue (US$, Mn) & (2020-2025)
Table 97. Organon Key News & Latest Developments
Table 98. Hansoh Corporate Summary
Table 99. Hansoh Antipsychotic Drug Product Offerings
Table 100. Hansoh Antipsychotic Drug Revenue (US$, Mn) & (2020-2025)
Table 101. Hansoh Key News & Latest Developments
Table 102. Hengrui Corporate Summary
Table 103. Hengrui Antipsychotic Drug Product Offerings
Table 104. Hengrui Antipsychotic Drug Revenue (US$, Mn) & (2020-2025)
Table 105. Hengrui Key News & Latest Developments
Table 106. Nhwa Group Corporate Summary
Table 107. Nhwa Group Antipsychotic Drug Product Offerings
Table 108. Nhwa Group Antipsychotic Drug Revenue (US$, Mn) & (2020-2025)
Table 109. Nhwa Group Key News & Latest Developments
Table 110. Yangtze River Pharmaceutical Group Corporate Summary
Table 111. Yangtze River Pharmaceutical Group Antipsychotic Drug Product Offerings
Table 112. Yangtze River Pharmaceutical Group Antipsychotic Drug Revenue (US$, Mn) & (2020-2025)
Table 113. Yangtze River Pharmaceutical Group Key News & Latest Developments
List of Figures
Figure 1. Antipsychotic Drug Product Picture
Figure 2. Antipsychotic Drug Segment by Type in 2024
Figure 3. Antipsychotic Drug Segment by Application in 2024
Figure 4. Global Antipsychotic Drug Market Overview: 2024
Figure 5. Key Caveats
Figure 6. Global Antipsychotic Drug Market Size: 2024 VS 2032 (US$, Mn)
Figure 7. Global Antipsychotic Drug Revenue: 2020-2032 (US$, Mn)
Figure 8. The Top 3 and 5 Players Market Share by Antipsychotic Drug Revenue in 2024
Figure 9. Segmentation by Type � Global Antipsychotic Drug Revenue, (US$, Mn), 2024 & 2032
Figure 10. Segmentation by Type - Global Antipsychotic Drug Revenue Market Share, 2020-2032
Figure 11. Segmentation by Application � Global Antipsychotic Drug Revenue, (US$, Mn), 2024 & 2032
Figure 12. Segmentation by Application - Global Antipsychotic Drug Revenue Market Share, 2020-2032
Figure 13. By Region - Global Antipsychotic Drug Revenue Market Share, 2020-2032
Figure 14. By Country - North America Antipsychotic Drug Revenue Market Share, 2020-2032
Figure 15. United States Antipsychotic Drug Revenue, (US$, Mn), 2020-2032
Figure 16. Canada Antipsychotic Drug Revenue, (US$, Mn), 2020-2032
Figure 17. Mexico Antipsychotic Drug Revenue, (US$, Mn), 2020-2032
Figure 18. By Country - Europe Antipsychotic Drug Revenue Market Share, 2020-2032
Figure 19. Germany Antipsychotic Drug Revenue, (US$, Mn), 2020-2032
Figure 20. France Antipsychotic Drug Revenue, (US$, Mn), 2020-2032
Figure 21. U.K. Antipsychotic Drug Revenue, (US$, Mn), 2020-2032
Figure 22. Italy Antipsychotic Drug Revenue, (US$, Mn), 2020-2032
Figure 23. Russia Antipsychotic Drug Revenue, (US$, Mn), 2020-2032
Figure 24. Nordic Countries Antipsychotic Drug Revenue, (US$, Mn), 2020-2032
Figure 25. Benelux Antipsychotic Drug Revenue, (US$, Mn), 2020-2032
Figure 26. By Region - Asia Antipsychotic Drug Revenue Market Share, 2020-2032
Figure 27. China Antipsychotic Drug Revenue, (US$, Mn), 2020-2032
Figure 28. Japan Antipsychotic Drug Revenue, (US$, Mn), 2020-2032
Figure 29. South Korea Antipsychotic Drug Revenue, (US$, Mn), 2020-2032
Figure 30. Southeast Asia Antipsychotic Drug Revenue, (US$, Mn), 2020-2032
Figure 31. India Antipsychotic Drug Revenue, (US$, Mn), 2020-2032
Figure 32. By Country - South America Antipsychotic Drug Revenue Market Share, 2020-2032
Figure 33. Brazil Antipsychotic Drug Revenue, (US$, Mn), 2020-2032
Figure 34. Argentina Antipsychotic Drug Revenue, (US$, Mn), 2020-2032
Figure 35. By Country - Middle East & Africa Antipsychotic Drug Revenue Market Share, 2020-2032
Figure 36. Turkey Antipsychotic Drug Revenue, (US$, Mn), 2020-2032
Figure 37. Israel Antipsychotic Drug Revenue, (US$, Mn), 2020-2032
Figure 38. Saudi Arabia Antipsychotic Drug Revenue, (US$, Mn), 2020-2032
Figure 39. UAE Antipsychotic Drug Revenue, (US$, Mn), 2020-2032
Figure 40. Johnson & Johnson Antipsychotic Drug Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 41. Pfizer Antipsychotic Drug Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 42. Eli Lilly Antipsychotic Drug Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 43. Bristol Myers Squibb Antipsychotic Drug Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 44. AstraZeneca Antipsychotic Drug Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 45. Sumitomo Dainippon Pharma Antipsychotic Drug Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 46. Allergan Antipsychotic Drug Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 47. Novartis Antipsychotic Drug Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 48. Cardinal Health Antipsychotic Drug Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 49. Sun Pharmaceutical Industries Antipsychotic Drug Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 50. GlaxoSmithKline Antipsychotic Drug Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 51. Sanis Health Antipsychotic Drug Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 52. Qilu Pharmaceutical Antipsychotic Drug Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 53. Otsuka Pharmaceutical Antipsychotic Drug Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 54. Vanda Pharmaceuticals Antipsychotic Drug Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 55. H.Lundbeck Antipsychotic Drug Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 56. Organon Antipsychotic Drug Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 57. Hansoh Antipsychotic Drug Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 58. Hengrui Antipsychotic Drug Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 59. Nhwa Group Antipsychotic Drug Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 60. Yangtze River Pharmaceutical Group Antipsychotic Drug Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
